Alnylam Pharmaceuticals, Inc.ALNY presented data at the annual meeting of the Oligonucleotide Therapeutics Society. Alnylam presented pre clinical data along with program guidance on ALN TTRsc02 for the treatment of TTR mediated amyloidosis (ATTR amyloidosis). Alnylam expects to file
Alnylam Offers Data on ALN-TTRsc02 & Platform Technology
